✦ LIBER ✦

PMS49 Cost-Effectiveness Analysis of Etanercept and Infliximab in the Treatment of Rheumatoid Arthritis (RA) in Spain

✍ Scribed by P. Guijarro; C. Crespo; M. Brosa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS22 COST-EFFECTIVENESS ANALYSIS OF ETA

✍ J. Vargas-Valencia; M. Sotelo-Guzmán; J.F. Mould-Quevedo; E. Muciño-Ortega; R.M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS14 Cost-Effectiveness Analysis of Eta

✍ Zhang, Y.; Yang, L.; Dong, P.; Xie, X.; Tang, B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

PMS49 COST-UTILITY ANALYSIS OF LEFLUNOMI

✍ Plisko, R; Krzystek, J; Lis, J; Rys, P 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PAR1 COST-EFFECTIVENESS ANALYSIS OF ETAN

✍ MG Saggia; FP Pina 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PMS19 COST-EFFECTIVENESS OF USING ETANER

✍ H Miadi-Fargier; B Fautrel; M Maravic; JP Daures; AL Ollivier; C Le Pen; F Maure 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

PMS70 COST-EFFECTIVENESS OF ETANERCEPT V

✍ X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB